Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients. Coyne K, Silverman P, Liu JH. Clin Breast Cancer 2020 May 26. pii: S1526-8209(20)30113.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Coyne K, Silverman P, Liu JH. Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients. Clin Breast Cancer 2020 May 26. pii: S1526-8209(20)30113.
PMID: 32616435